DataKnowledgeCloudtrainingcoordination

L1000 LINCS DCIC FIBR034 MCLF100SZ 6H G13 fluoxetine 4uM.tsv.gz (File)

Taxon:

Homo sapiens

Taxon (Entity type)

Subject:

MCLF100SZ

Subject (Entity type)

Project:

LINCS-2021

Project (Entity type)

File Format:

TSV

File Format (Entity type)

Dcc Asset:

datapackage.zip

Processed File (Entity type)

Dcc:

LINCS

DCC (Entity type)

Data Type:

gene expression profile

Data Type (Entity type)

Compression Format:

GZIP format

File Format (Entity type)

Biosample:

L1000 LINCS DCIC 2021 FIBR034 MCLF100SZ 6H G13 fluoxetine 4uM

Biosample (Entity type)

Assay Type:

landmark transcript profiling assay

Assay Type (Entity type)

Uncompressed Size In Bytes:311 KB

Size In Bytes:131 KB

Sha256:254b642cd7dc53cacbc9a11e18f4703b4d7b093449f85187e3271324f9ec9b18

Persistent Id:drs://drs.lincs-dcic.org/593a7f8833380d317093ec24ca8c4bef

Mime Type:application/gzip

Md5:593a7f8833380d317093ec24ca8c4bef

Filename:L1000_LINCS_DCIC_FIBR034_MCLF100SZ_6H_G13_fluoxetine_4uM.tsv.gz

Creation Time:2021-01-21T00:00:00

Access Url:

drs://drs.lincs-dcic.org/593a7f8833380d317093ec24ca8c4bef

Results found

Linked to

	Label	Description
	L1000 LINCS DCIC 2021 FIBR034 MCLF100SZ 6H G13 fluoxetine 4uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 FIBR034 MCLF100SZ 6H G13 fluoxetine 4uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.